2024-10-12 - Analysis Report
## Danaher Corp (DHR) Stock Analysis Report

**Company Overview:** Danaher Corp is a global science and technology company that designs, manufactures, and markets a wide range of products and services.

**Performance Analysis:**

**1. Performance vs. S&P 500 (VOO):**

* **Cumulative Return (DHR):** 241.7%
* **Cumulative Return (VOO):** 134.11%
* **Outperformance:** 107.59% (48.46% relative to historical range)

DHR has significantly outperformed the S&P 500, achieving over 100% more cumulative return.  The current outperformance is within the top 48.46% of its historical range.

**2. Recent Price Movement:**

* **Closing Price:** $266.21
* **5-Day Moving Average:** $268.61
* **20-Day Moving Average:** $272.75
* **60-Day Moving Average:** $269.55

The stock price is currently trading below its 5-day, 20-day, and 60-day moving averages, suggesting potential downward pressure.

**3. Technical Indicators:**

* **RSI:** 40.2 (below 50, indicating oversold conditions)
* **PPO:** -0.4 (negative, suggesting potential weakness)
* **Delta_Previous_Relative_Divergence:** -6.46 (negative, indicating a recent downward trend in relative performance)
* **Expected_Return:** 24.29% (over 5 years compared to S&P 500)

The technical indicators suggest a potential short-term decline, but the strong expected return indicates long-term growth potential.

**4. Recent Earnings & Forecast:**

| Date        | EPS  | Revenue     |
|-------------|------|-------------|
| 2024-07-23 | 1.23 | $5.74 Billion |
| 2024-04-23 | 1.47 | $5.80 Billion |
| 2024-02-21 | 1.46 | $6.41 Billion |
| 2023-10-24 | 1.53 | $5.62 Billion |
| 2023-07-25 | 1.53 | $5.62 Billion |

The most recent earnings report for Q2 2024 (released on 2024-07-23) showed EPS of $1.23, slightly below the analyst estimate of $1.26. Revenue of $5.74 Billion came in line with expectations. The company has been consistently profitable and has shown steady revenue growth, with the most recent quarter showing a slight dip compared to the previous quarter.

**5. News & Recent Issues:**

**Recent Market Outlook:** 
* Danaher's strong performance and history of innovation have continued to attract investor interest. 
* The company is expected to benefit from the ongoing global economic recovery and rising demand in key markets such as life sciences and diagnostics.
* However, the stock price has been impacted by macroeconomic uncertainties and rising interest rates.

**Analyst Opinions:**
* Most analysts maintain a positive outlook on Danaher, with a consensus "Buy" rating. 
* They cite the company's strong growth prospects, consistent profitability, and diverse portfolio as key factors driving their optimism.

**Performance Highlights:**
*  FINBOLD highlighted Danaher's strong performance in its Q2 2024 earnings report, noting the company's ability to navigate supply chain challenges and maintain strong growth.
*  The company's recent acquisitions and strategic investments have been well-received by investors, demonstrating its commitment to innovation and expansion.

**6. Overall Analysis:**

Danaher Corp (DHR) has a history of strong financial performance and consistent growth, outperforming the market significantly. While recent price movements suggest some short-term weakness, the company's long-term prospects remain positive. Investors with a long-term horizon might consider DHR as a promising investment opportunity. However, it's crucial to monitor macroeconomic trends and industry-specific developments closely, as they can impact the company's performance.

**7. Disclaimer:** 

This analysis is for informational purposes only and does not constitute investment advice. Always consult with a qualified financial advisor before making any investment decisions.
